PetDx
La Jolla
About PetDx
PetDx® – The Liquid Biopsy Company for Pets is a San Diego-based molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health. The company's flagship product, OncoK9®, enables veterinarians to detect cancer in dogs with a simple blood draw. As a first-in-class multi-cancer early detection (MCED) test, OncoK9 employs cutting-edge genomic analysis that leverages next-generation sequencing (NGS) technology and proprietary bioinformatics algorithms, empowering veterinarians to provide superior care to canine patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $72.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2021)
- Website: petdx.com
- Phone: 833-464-7297
Industries & Categories
Biotechnology, Health Diagnostics, Life Science, Pet, Veterinary
Social Profiles
Canonical: https://fsome.com/organization/petdx-103727 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.